Japan AED Makers See At Least 13 Percent Sales Decline This Fiscal Year
This article was originally published in PharmAsia News
Executive SummaryTwo Japan-based medical-device makers see reduced sales of automated external defibrillators holding down operating profits for the fiscal year that began in April. Nihon Kohden forecasts a fall of 13 percent in AED sales, including in the United States and other countries where cost-cutting is under way. Fukuda Denshi expects a bigger drop in AED sales, by 16 percent. (Click here for more - a subscription may be required
You may also be interested in...
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.